Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov 22;11(11):1279.
doi: 10.3390/life11111279.

HPV and Recurrent Respiratory Papillomatosis: A Brief Review

Affiliations
Review

HPV and Recurrent Respiratory Papillomatosis: A Brief Review

Amr Mohamed Ouda et al. Life (Basel). .

Abstract

Recurrent Respiratory Papillomatosis (RRP) is a rare but severe manifestation of human papillomavirus (HPV). As our knowledge about HPV infections has expanded, it has become possible to understand the course of RRP disease and unravel plausible efficient methods to manage the disease. However, the surge in reports on HPV has not been accompanied by a similar increase in research about RRP specifically. In this paper, we review the clinical manifestation and typical presentation of the illness. In addition, the pathogenesis and progression of the disease are described. On the other hand, we discuss the types of treatments currently available and future treatment strategies. The role of vaccination in both the prevention and treatment of RRP will also be reviewed. We believe this review is essential to update the general knowledge on RRP with the latest information available to date to enhance our understanding of RRP and its management.

Keywords: HPV; HPV infection; children; recurrent respiratory papillomatosis; vaccine.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Outline of HPV type 6 and 11 infection pathways. Although RRP is not a malignancy, it can progress to cancer following further genomic deregulation caused by other oncogenes or oncoviruses.

References

    1. Langer C., Wittekindt C., Wolf G. Laryngeal Recurrent Respiratory Papillomatosis: Current Aspects on Diagnosis and Therapy. Laryngorhinootologie. 2019;98:577–587. doi: 10.1055/a-0896-9729. - DOI - PubMed
    1. Derkay C.S., Bluher A.E. Update on Recurrent Respiratory Papillomatosis. Otolaryngol. Clin. N. Am. 2019;52:669–679. doi: 10.1016/j.otc.2019.03.011. - DOI - PubMed
    1. Fortes H.R., von Ranke F.M., Escuissato D.L., Araujo Neto C.A., Zanetti G., Hochhegger B., Souza C.A., Marchiori E. Recurrent respiratory papillomatosis: A state-of-the-art review. Respir. Med. 2017;126:116–121. doi: 10.1016/j.rmed.2017.03.030. - DOI - PubMed
    1. Seedat R.Y. Juvenile-Onset Recurrent Respiratory Papillomatosis Diagnosis and Management—A Developing Country Review. Pediatric Health Med. Ther. 2020;11:39–46. doi: 10.2147/PHMT.S200186. - DOI - PMC - PubMed
    1. San Giorgi M.R., van den Heuvel E.R., Tjon Pian Gi R.E., Brunings J.W., Chirila M., Friedrich G., Golusinski W., Graupp M., Horcasitas Pous R.A., Ilmarinen T., et al. Age of onset of recurrent respiratory papillomatosis: A distribution analysis. Clin. Otolaryngol. 2016;41:448–453. doi: 10.1111/coa.12565. - DOI - PubMed